Skip to main contentSkip to navigation
Sirius Investors
Bionovate Technologies Corp

Bionovate Technologies Corp

BIIO
OTCHealthcare

Bionovate Technologies Corp (BIIO) Investment Research Dashboard

About Bionovate Technologies Corp (BIIO) stock analysis

Get live BIIO stock price $0.00, comprehensive Bionovate Technologies Corp stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BIIO stock data and investment insights.

0.00
0.00%Today
Market Cap
775
Volume
100
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat t...

Company Information

CEO
Timothy Jones
Sector
Healthcare
Industry
Medical - Devices
Employees
0

Contact Information

Address
Gewerbestrasse 10
Country
CH

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -2.51) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Bionovate Technologies Corp shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Bionovate Technologies Corp
  • Investors should consider how Bionovate Technologies Corp fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

775

P/E Ratio (TTM)

-0.01

Beta

-2.51

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

69/100 ⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.6%+2.6%+3.7%19.2
98/100⭐⭐⭐⭐⭐
Consumer Defensive+1.4%+3.5%+2.4%30.2
78/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.1%+1.4%24.0
69/100⭐⭐⭐⭐
Communication Services+0.6%-1.4%+2.2%22.0
67/100⭐⭐⭐⭐
Basic Materials+0.7%+1.5%+0.0%25.2
66/100⭐⭐⭐⭐
Real Estate+0.2%+0.7%-1.8%29.4
50/100⭐⭐⭐
Energy-0.5%-2.2%-2.6%19.4
41/100⭐⭐⭐
Utilities-0.8%+0.2%-4.2%26.9
36/100⭐⭐
Consumer Cyclical+0.2%-1.8%-6.1%42.6
18/100
Industrials-0.4%-0.6%-10.8%29.8
18/100
Technology-0.7%-2.9%-8.3%40.1
8/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.